LRRK2 and Parkinson disease: Basal levels of phospho-NFAT3 were significantly higher in LRRK2 G2019S neurons than in controls, further corroborating the inhibitory effect of the PD-associated LRRK2 mutation on NFAT shuttling (Supplementary Fig. 3E, F).